Name | GIDROSTAL'KONSTRUKTSIYA, ZAO |
|---|
INN | 5048024538 |
|---|
KPP | 504801001 |
|---|
OGRN | 1105048001926 |
|---|
OKPO | 68121258 |
|---|
Address | 142300, Moskovskaya Oblast', g. Chekhov, ul. Chekhova, d. D. 20A |
|---|
Phone | +7 (496) 723-28-97 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 25.11 | Core activity | Manufacture of metal structures, products and their parts | | 25.29 | Additional activity | Manufacture of other tanks, reservoirs and containers | | 25.61 | Additional activity | The processing of metals and coating | | All types of activities | | 25.62 | Additional activity | Treatment and coating of metals | | 28.22.42 | Additional activity | Manufacture of other cranes | | 43.99.5 | Additional activity | installation of structural steel works | | 52.10.9 | Additional activity | Khranenie i skladirovanie prochikh gruzov | | 52.24.2 | Additional activity | Transport operations with other cargoes |
Registration date | 23.08.2010 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po g.Chekhovu Moskovskoy oblasti |
|---|
|
GSK, ZAO (Moscow Oblast; INN 5048024538) was registered on 23 Aug 2010. The company's authorized capital as of July 1, 2012 was 1000000 rub. Type of ownership of GSK, ZAO - Closed joint-stock companies. Form of ownership of GSK, ZAO - Combines private and foreign property. Principal activities of GSK, ZAO: manufacture of metal structures, products and their parts (25.11), manufacture of other tanks, reservoirs and containers (25.29), the processing of metals and coating (25.61). |
Economic indicators2023
Net profit (RAS) of GSK, ZAO dropped in 2023 2.14 times to 139.00 thousand RUB from 298.00 thousand RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 18.26% to 108.50 million RUB from 91.75 million RUB over 2022; cost of goods sold grew 2.90 times to 53.80 million RUB from 18.55 million RUB; sales profit went up by 12.80% to 6.20 million RUB from 5.49 million RUB. 2020
Net profit (RAS) of GSK, ZAO dropped in 2020 4.18 times to 653.00 thousand RUB from 2.73 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period 2.12 times to 118.62 million RUB from 251.68 million RUB in 2019; cost of goods sold decreased 4.00 times to 43.13 million RUB from 172.71 million RUB; sales profit fell by 3.48% to 2.55 million RUB from 2.64 million RUB. 2019
Net profit (RAS) of GSK, ZAO grew over 2019 by 6.89% to 2.73 million RUB from 2.55 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 26.88% to 251.68 million RUB from 344.21 million RUB in 2018; cost of goods sold decreased by 27.17% to 172.71 million RUB from 237.13 million RUB; sales profit fell 4.84 times to 2.64 million RUB from 12.78 million RUB. 2018
Net profit (RAS) of GSK, ZAO dropped in 2018 2.77 times to 2.55 million RUB from 7.06 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period 1.86 times to 344.21 million RUB from 184.72 million RUB over 2017; cost of goods sold grew 2.81 times to 237.13 million RUB from 84.35 million RUB; sales profit went up by 37.37% to 12.78 million RUB from 9.30 million RUB. 2017
Net profit (RAS) of GSK, ZAO grew over 2017 by 25.77% to 7.06 million RUB from 5.62 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 11.94% to 184.72 million RUB from 209.76 million RUB in 2016; cost of goods sold decreased by 31.51% to 84.35 million RUB from 123.15 million RUB; sales profit fell by 12.20% to 9.30 million RUB from 10.59 million RUB. 2016
Net profit (RAS) of GSK, ZAO dropped in 2016 by 30.56% to 5.62 million RUB from 8.09 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 22.01% to 209.76 million RUB from 268.94 million RUB in 2015; cost of goods sold decreased by 22.01% to 123.15 million RUB from 157.90 million RUB; sales profit fell by 45.86% to 10.59 million RUB from 19.56 million RUB. 2014
Net profit (RAS) of GSK, ZAO dropped in 2014 by 1.96% to 3.76 million RUB from 3.83 million RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period 2.43 times to 173.11 million RUB from 420.32 million RUB in 2013; cost of goods sold decreased 3.46 times to 85.57 million RUB from 296.24 million RUB; sales profit fell 3.46 times to 10.19 million RUB from 35.26 million RUB. 2013
Net profit (RAS) of GSK, ZAO dropped in 2013 10.43 times to 3.83 million RUB from 39.95 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period 1.59 times to 420.32 million RUB from 264.48 million RUB over 2012; cost of goods sold grew 2.64 times to 296.24 million RUB from 112.32 million RUB; sales profit went up by 6.21% to 35.26 million RUB from 33.20 million RUB. 2012
Net profit (RAS) of GSK, ZAO grew over 2012 16.60 times to 39.95 million RUB from 2.41 million RUB over 2011, the company informed. Cost of goods sold decreased by 31.91% to 112.32 million RUB from 164.95 million RUB; sales profit went up 3.78 times to 33.20 million RUB from 8.77 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|